Northeast Has Nearly $8 Billion Worth of Reasons to Love Life Science Industry CAPEX/MRO Investments

SUGAR LAND--April 26, 2015--Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--Like any long-term union, the one shared between the U.S. Northeast Region, which comprises Delaware, New Jersey, New York and Pennsylvania, and the Life Science Industry is a classic example of a love/hate relationship. The Northeast Region has been pummeled over the past few years with scores of pharmaceutical plants closing and lucrative jobs lost. On the other hand, the region remains a favorite for capital investment from both the private and public sectors for new and upgraded life science manufacturing plants and research centers. Currently, there are 168 active reported projects translating to a hefty $7.7 billion in total investment value (TIV). Within this article: Lists three major projects in the Northeast Region that Industrial Info is tracking. Additional companies: Regeneron Pharmaceuticals Incorporated (NASDAQ:REGN)